SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) – Intra-Cellular Therapies, Inc. Transaction History
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) portfolio value:
$17.83M
portfolio value
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) quarter portfolio value change:
-18.48%
quarter
Intra-Cellular Therapies, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -4.04M | $46.53 | 383.56K | |
| Q2 2022 | share | Decrease | -2.14% | -8.37K shares | -2.08M | $57.08 | 383.56K |
| Q1 2022 | share | Decrease | -1.10% | -4.34K shares | 3.30M | $61.19 | 391.93K |
| Q4 2021 | share | Increase | +35.50% | 103.81K shares | 9.78M | $52.13 | 396.27K |
| Q3 2021 | share | 0.00% | 0 shares | -1.05M | $37.28 | 292.46K | |
| Q2 2021 | share | Increase | +1037.02% | 266.74K shares | 11.06M | $40.82 | 292.46K |
| Q1 2021 | share | Increase | 0.00% | 25.72K shares | 874K | $33.93 | 25.72K |